title: Bupropion for attention deficit hyperactivity and comorbid disorders.
abstract: Bupropion is a unique antidepressant with noradrenergic and to a lesser extent dopaminergic effects. These have led investigators to explore bupropion's efficacy in attention deficit hyperactivity disorders, which are believed to be related to aberrations in catecholamines. An expanding body of research has demonstrated bupropion's efficacy in attention deficit hyperactivity disorders over the lifespan. Despite early reports of seizures in select samples, bupropion is generally well-tolerated. While stimulants remain the first-line pharmacological treatments for attention deficit hyperactivity disorders, bupropion offers promise as a medication that treats not only attention deficit hyperactivity disorders, but also common comorbid disorders, including unipolar and bipolar depression, anxiety and substance abuse.
authors.affiliation: Department of Psychiatry, University of Pittsburgh Medical Center, 3811 0'Hara Drive, Pittsburgh, PA 15213, USA. davisswb@msx.upmc.edu
authors.forename: W Burleson
authors.initials: WB
authors.lastname: Daviss
authors.forename: Raymond J
authors.initials: RJ
authors.lastname: Pan
authors.forename: James M
authors.initials: JM
authors.lastname: Perel